NCI SBIR/STTR Omnibus (NIH-wide) + NCI SBIR Contracts
Supports small business teams in cancer innovation through National Cancer Institute routes that combine federal opportunity channels and direct contract activity.
About
NCI's SBIR and STTR offering has two faces: the NIH-wide omnibus that includes NCI and the NCI-issued SBIR contract solicitations for cancer-specific needs. It is aimed at small U.S. businesses building cancer diagnostics, therapeutics, and other enabling technologies, with award sizes from $300,000 to $2 million and a median actual award around $500,000.
The omnibus uses R43/R44 SBIR and R41/R42…
AIBiotechHardwareAdvanced MaterialsMedtech
Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.